- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 118.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 121.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 115.87M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $23K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$848K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.87M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $200K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.44M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.81M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.47M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.16M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $15.28M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $13.76M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $15.28M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.76M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $15.13M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.26M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.09M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $15.23M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.51M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | $115K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$852K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $353K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$921K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.9M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $1.4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $8.53M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $2.84M |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.43M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $4.23M |